Editorial: Multi-targeted tyrosine kinase inhibitors in the treatment of cancer and neurodegenerative disorders

Front Chem. 2024 Jul 26:12:1460347. doi: 10.3389/fchem.2024.1460347. eCollection 2024.
No abstract available

Keywords: Abl and Src tyrosine kinases; HER-2 (ErbB2); apoptosis; cancer; downstream signalling; epidermal growth factor receptor (EGFR); tyrosine kinase Inhibition.

Publication types

  • Editorial